In addition, it was reported that EGFR mutation frequency in NSCLC patients was ethnicity-dependent, with an incidence rate of ~30% in Asian populations and ~15% in Caucasian populations. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.